Thyroid cancer is growing its roots everywhere. Different treatment approaches are utilized for treating thyroid cancer but precision medicine has been one such approach that has gain impetus in the modern era. By coupling with genetics, it has assisted in pre-operative diagnosis in cancer patients and refinement of new therapies. This exclusive KOL Interview, explains how the field of precision medicine has evolved and assisted in developing new therapies.
Dr. Brian Haugen is the Professor of Medicine & Pathology Head at the Division of Endocrinology, Metabolism & Diabetes. Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets.
